Peter Libby, M.D. – Program co-chair
Mallinckrodt Professor of Medicine
Harvard Medical School

Jean-Claude Tardif, M.D. – Program co-chair
Director, Research Center
Montreal Heart Institute

Eric Abadie, M.D.
Director, Therapeutics Evaluation, AFSSAPS
European Medicines Agency (EMEA)

Christine Albert, M.D., MPH
Director, Center for Arrhythmia Prevention
Harvard Medical School
Boston, MA

Jonathan Allis, M.D.
Global Head of Imaging
GE Healthcare Diagnostics

Todd Anderson
Director, Foothills Hospital

Naomi Aronson, Ph.D.
Executive Director
Technology Evaluation Center
Blue Cross and Blue Shield Association
Chicago, IL

Robert S. Balaban, M.D., Ph.D.
National Heart, Lung and Blood Institute National Institutes of Health

Christie Ballantyne, M.D.
Director, Ctr. for Cardiovascular Disease Prev.
Baylor College of Medicine

Philip Barter, M.D.
Professor of Medicine
University of Sydney

Russell Basser, M.D.
Global Director of Clinical Development
CSL, Ltd.

Colin Berry, BSc., M.D., Ph.D.
Cardiovascular MRI / CV Intervention Program
NHLBI, National Institutes of Health

Donald M. Black, MBA, M.D.
Global Head of Research and Development
General Electric Healthcare

Melanie Blank, M.D.
Division of Cardiovascular and Renal Products
CDER, FDA

Eric P. Brass, M.D., Ph.D.
Professor of Medicine
Harbor-UCLA Medical Center

H. Bryan Brewer, Jr., M.D.
Director of Lipoprotein and Atherosclerosis Research
MedStar Research Institute

Greg Brown
University of Washington

David G. Brown, Ph.D.
NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems
US FDA

W. Virgil Brown, M.D.
Charles Howard Candler Professor of Medicine
Emory University School of Medicine
Atlanta, GA

Michael A. Browlee, MD
Albert Einstein College of Medicine

Robert M. Califf, M.D.
Vice Chancellor for Clinical Research
Director, Duke Translational Medicine Institute
Durham, NC

Gregory Campbell, Ph.D.
Director, Division of Biostatistics
US FDA, CDRH

Christopher Cannon, M.D.
Associate Prof. of Medicine,
Brigham and Women's Hospital

Gao Chenyan, M.D.
Director of Division VII
Center of Drug Evaluation, China SFDA
Beijing, China

Eric Colman, M.D.
Division of Metabolism and Endocrine
Center for Drug Evaluation and Research, US FDA

Carolyn C. Compton, M.D., Ph.D.
Director, Office of Biorepositories and Biospecimen Research (OBBR)
National Cancer Institute, National Institutes of Health

Douglas Cowart, Pharm.D.
Association of Clinical Research Organizations

Hayes Dansky, M.D.
Director, Cardiovascular Disease
Merck Research Laboratories

Michael Davidson, M.D.
Director of Preventive Cardiology
University of Chicago School of Medicine

Jean Davignon, M.D.
Director Hyperlipidemia and Athero Research
Clinical Research Institute of Montreal
Professor of Medicine, University of Montreal
Montreal, Quebec

John Deanfield
British Heart Foundation

Clarissa Desjardins, PhD, CEO
Center of Excellence in Personalized Medicine

James De Lemos, M.D.
Associate Professor and CCU Director
University of Texas-Southwestern Medical School

Marcelo Di Carli, M.D.
Chief, Nuclear Medicine
Brigham and Women's Hospital

Pamela S. Douglas, M.D.
Director, DCRI CV Imaging Program
Duke University Medical Center

Benjamin Eloff, Ph.D.
Office of Scientific and Medical Programs
Office of the Commissioner, US FDA

Zahi A. Fayad, Ph.D.
Professor, Departments of Radiology and Med.
Mount Sinai School of Medicine

Giora Feuerstein, MD
Head, Discovery Translational Medicine
Wyeth Research

Felix W. Frueh, Ph.D.
Vice President, R&D Personalized Medicine
Medco Health Solutions, Inc.

Brandon D. Gallas, Ph.D.
NIBIB/CDRH Laboratory for the Assessment of Medical Imaging Systems
US FDA

Jean-Jacques Garaud, M.D.
Head of Global Drug Development
F. Hoffmann-La Roche Ltd

Alan J. Garber, M.D., Ph. D.
Professor, Medicine, Biochemistry,
Molecular and Cellular Biology
Baylor College of Medicine
Houston, TX

Federico Goodsaid, Ph.D.
Office of Clinical Pharmacology
Center for Drug Evaluation and Research, US FDA

Mark Grant, M.D.
Senior Scientist, Technology Evaluation Center
Blue Cross Blue Shield Association

Steven Gutman, M.D.
Director, Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiologic Health, FDA
Silver Spring, MD

Rory Hachamovitch, M.D.
Department of Medicine
University of Southern California
Los Angeles, CA

Robert Harrington
Duke University

Patricia P. Harlow, Ph.D.
Division of Cardiovascular and Renal Drug Products
US FDA, CDER

Thomas Hatsukami
Vascular Surgery, Washington University

Stan Hazen
Cleveland Clinic Foundation

Jay Heinecke, M.D.
Professor of Medicine
University of Washington

Therese Heinonen, D.V.M.
Associate Director, Medical and
Scien. Affairs
Montreal Heart Institute Coord. Center

Seigo Izumo, M.D., Ph.D.
Vice President and Global Head CV Research
Novartis Institutde for Biomedical Research

Hylton Joffe, M.D.
Division of Metabolism and Endocrine
Center for Drug Evaluation and Research, US FDA

Dominique Johnson, Ph.D.
Director Montreal Heart Institute Coord. Center

John Kastelein
Chair, Genetics in CV Disease, University of Amsterdam

Agnes Klein, M.D.
Director, Ctr. for Eval. of Radiopharm. and Biotherapeutics, Health Canada

Michael Klimas, Ph.D.
Executive Director, Imaging Franchise Lead
Merck & Co., Inc.

Wolfgang Koenig, M.D.
Professor of Medicine and Cardiology
University of Ulm Medical Center

Lewis Kuller
Chair Epidemiology, University of Pittsburgh

Jeff Leiden, M.D., Ph.D.
Managing Director
Clarus Ventures

Lawrence Leiter, M.D.
Head, Endocrinology and Metabolism
St. Michael's Hospital, Toronto

Claude Lenfant
Director, NIH, NHLBI

Daniel Levy, MD
Director, Framingham Heart Study
Director, Center for Population Studies
National Heart, Lung, & Blood Institute
Bethesda, MD

João A.C. Lima, M.D.
Assoc. Prof. of Med., Rad. and Epidemiology
Johns Hopkins University

Ray Lipicky
Former Director, Cardio-Ranal, FDA

Peter Liu, MD.
Scientific Director
Canadian Institutes of Health Research

Elizabeth Mansfield, Ph.D.
Senior Policy Analyst, Office of In Vitro Diag. Device Eval. and Safety, CDRH, USFDA

Bruce McManus, M.D., Ph.D.
Professor and Director, The James Hogg iCAPTURE Centre
University of British Columbia - St. Paul's Hospital
Scientific Director, The Heart Centre - Providence Health Care
Vancouver, British Columbia

David O. Meltzer, M.D., Ph.D.
Director of the Center for Health and Social Sciences
Department of Medicine and Dept. of Economics
University of Chicago
Chicago, IL

George A. Mensah, M.D.
National Ctr. for Chronic Dis. Prev. and Health Prom., Centers for Disease Control and Prevention

Michele Mercuri, M.D., Ph.D.
Head Pharma Scientific Review Committee
Novartis Pharmaceuticals Corp.

George Mills, M.D.
Vice President, Medical Imaging Consulting
Perceptive Informatics

Gary F. Mitchell, M.D.
Cardiovascular Engineering, Inc.
Waltham, MA

Jacques Mizrahi, M.D.
Head, Metabolic Diseases
F. Hoffmann-LaRoche

Vincent Mooser, M.D.
Clinical Pharmacology and Disc. Med.
GlaxoSmithKline

C. Daniel Mullins, PhD.
Professor, Pharmacoeconomics
University of Maryland

Elizabeth Nabel
Director, NHLBI, NIH

Steve Nissen
Director, Cleveland Clinic Foundation

Minh Nguyen
University of Florida

Christopher O'Donnell, M.D.
Senior Advisor, Genome Research
NHLBI, National Institutes of Health

Daniel O'Leary
Chairman Radiology, New England Medical Center

David Orloff, M.D.
Executive Director, Reg Affairs
Medpace Inc.

Mary Parks, M.D.
Division of Metabolism and Endocrine
Center for Drug Evaluation and Research, US FDA

Michael Perelman, M.D.
Vice President, Global Project Mgmt
Schering-Plough Research Institute

Marc Pfeffer, M.D., Ph.D.
Professor of Medicine
Harvard Medical School
Boston, MA

Michael S. Phillips, Ph.D.
Director of Pharmacogenomics
Genome Quebec
Montreal, Quebec

Robert Powell, PharmD
Director, Pharmacometrics
Office of Clinical Pharmacology
Center for Drug Evaluation and Research
US Food and Drug Administration
Silver Spring, MD

Daniel Rader
University of Pennsylvania

Paolo Raggi
Director, Preventive Cardiology, Tulane

Joel Raichlen, M.D.
Senior Director, Clinical Research
Astra-Zeneca

Gurvaneet Randhawa, M.D.
Center for Outcomes and Evidence
Agency for Healthcare Research and Quality

Paul M. Ridker, M.D.
Center for Cardiovascular Disease Prevention
Brigham and Women’s Hospital

Dwaine Rieves, M.D.
Director, Medical Imaging
Center for Drug Evaluation and Research, US FDA

John Rioux, Ph.D.
The Lab of Genetics and Genomic Med of Inflam., Montreal Heart Institute

Jean Rouleau, M.D.
Dean of Medicine
University of Montreal

Army E. Rudolph, Ph.D.
Director, Glob. Med CV Metabolic Endocrine
Pfizer, Inc

Kerry-Anne Rye, Ph.D.
Head, Lipid Research Group
The Heart Research Institute, Sydney, AU

Philip Sager, M.D.
Chief Medical Officer
CardioDx, Inc.

William J. Sasiela, Ph.D.
Chief Medical Officer
Aegerion Pharmaceuticals, Inc.

Ernst Schaefer, M.D.
Director, Lipid Metabolism Laboratory
Tufts University
Boston, MA

Daniel Schultz, M.D.
Director, Center for Devices and Radiological Health
US Food and Drug Administration
Rockville, MD

David Smalley, Ph.D.
Assistant Professor Cardiovascular Research Center
University of Virginia

Carl Sparrow, Ph.D.
Director, Lipid Biochemistry
Merck Research Laboratories

J. David Spence, M.D.
Director, Stroke Prevention and
Athero Research Centre
Robarts Research Institute
London, Ontario, CANADA

Ton van der Steen
Biomedical Tech in Cardiologym Thorax Center, Rotterdam

George Steiner
University of Toronto

Norman Stockbridge, M.D.
Division of Cardio-Renal, Center for Drug Evaluation and Research, US FDA

Erik Stroes, M.D., Ph.D.
Department of Vascular Medicine
Academic Medical Center, Amsterdam

Anders Svensson, M.D.
Head of Clinical Development - Metabolism
F. Hoffman-LaRoche, Ltd.

Alan Tall, M.D.
Professor of Medicine
Columbia University

Allen Taylor, M.D.
Chief, Cardiology Service
Walter Reed Army Medical Center

Ahmed Tawakol, M.D.
Professor of Medicine
Massachusetts General Hospital

Robert Temple, M.D.
Director, Office of Medical Policy
US FDA

Douglas C. Throckmorton, M.D.
Deputy Center Director, Center for Drug Evaluation and Research, US FDA

Paula R. Trumbo, Ph.D.
Team Leader, Nutrition Science Eval. Center for Food Safety and App. Nutrition, US FDA

Roger Ulrich, Ph.D.
Chief Development Officer
Callistoga Pharmaceuticals

John Wagner, MD, Ph.D.
Director, Clinical Pharmacology
Merck & Co., Inc.

David Waters, M.D.
Chief, Cardiovascular Medicine
University of California, San Francisco

G. Russell Warnick, M.S., MBA
Chief Scientific Officer
Berkeley HeartLab, Inc.

Ralph Weissleder, M.D., Ph.D.
Director, Center for Molecular Imaging Research
Professor of Radiology, Harvard Medical School
Boston, MA

James J. Zhang, M.D., Ph.D., MBA
Global Clinical Development
Siemens Molecular Imaging, Inc.
Siemens Medical Solutions USA

Bram Zuckerman, M.D.
Director, Center for Devices and Radiological Health, US FDA

ver. 07.16.10